alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
### Request for Information Drone Aerial Producti ons, LLC (FAA-2015-3217) 9-AWA-AVS-333Exemptions (FAA)

Dear Ms. Rowden: This letter is to inform you that the following information is missing from your petition (Docket No. FAA

− 2015

− 3217). This information is necessary for the Federa l Aviation Administration (FAA) to process your p etition.

z Provide a copy of the Motion Picture and Television Op erations Manual (MPTOM) wh ich is required by Order 8900.1, Volume 3, Chapter 8, Section 1. If you wish for us to proceed without this manual and remove closedset filming from your proposed operation please inform of us of your intention by the requested response date listed below. Please submit the additional informati on (non-proprietary) to your docket at www.regulations.gov . Once your information has been submitted, plea se also send a copy of the requested information (and any proprietary information), as well as your comm ent tracking number from regulations.gov via e-mail to 333exemptions@faa.gov. I f you want us to process your request any further, we mu st receive the information de scribed above by December 8, 2015. If we do not receive the information, we wi ll close the docket without notifying you further. If you have any questions, please feelfree to contact me at (202) 267-2999. FAA Office o f Rulemakin g Sent : T uesday , November 24, 2015 12:57 PM To: diane.rowden@gmail.com
### SUBCHAPTER XIV—COMPENSATION FOR PRIVATE PROPERTY ACQUIRED
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Surgical Sciences, Biomedical Imaging and Bioengineering Integrated Review Group; Surgery, Anesthesiology and Trauma Study Section.                    

*Date:*                         February 6-7, 2019.                    

*Time:*                         8:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD 20814.                    

*Contact Person:*                         Weihua Luo, MD, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5114, MSC 7854, Bethesda, MD 20892, (301) 435-1170,                         *luow@csr.nih.gov.*

This meeting notice is being published less than 15 days in advance of the meeting due to the partial Government shutdown of December 2018.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: January 18, 2019.

Sylvia L. Neal,

Program Analyst, Office of Federal Advisory Committee Policy .

[FR Doc. 2019-00178 Filed 1-28-19; 8:45 am]

 BILLING CODE 4140-01-P
### Part B—Miscellaneous Provisions

#### **Editorial Notes**

#### Codification

This part was classified to subchapter XXV (§300aaa et seq.) of this chapter prior to its renumbering by Pub. L. 103–43, title XX, §2010(a)(1)–(3), June 10, 1993, 107 Stat. 213.
1

The Honorable H. David Young, United States Magistrate Judge for the

Eastern District of Arkansas, to whom the case was referred for final disposition by

consent of the parties pursuant to 28 U.S.C. § 636(c).

United States Court of Appeals

FOR THE EIGHTH CIRCUIT

___________

No. 02-1737

___________

Ronald Mitchell, *

*

Appellant, *

*

v. * Appeal from the United States

* District Court for the

Sgt. Kirk, Pulaski County Regional * Eastern District of Arkansas.

Detention Facility; Sgt. M. Yates, * [UNPUBLISHED]

Pulaski County Regional Detention *

Facility; Gerald Bennett, Deputy, *

Pulaski County Regional Detention *

Facility, *

*

Appellees. *

___________

 Submitted: September 4, 2002

 Filed: September 10, 2002

___________

Before McMILLIAN, LOKEN, and MURPHY, Circuit Judges.

___________

PER CURIAM.

Ronald Mitchell appeals the district court’s1

 order dismissing his 42 U.S.C.

§ 1983 action with prejudice upon Mitchell’s refusal to participate in his trial.
-2-

Although Mitchell was displeased with the district court’s pretrial rulings to exclude

certain witnesses and documentary evidence, we find no abuse of discretion in the

district court’s refusal to grant Mitchell’s pro se request, on which his counsel did not

comment, for a continuance. See Rydder v. Rydder, 49 F.3d 369, 373 (8th Cir. 1995)

(standard of review). Given the denial of Mitchell’s request for a continuance and his

refusal to participate at trial, we conclude the district court was left with little choice

and did not abuse its discretion in following through with its admonishment that

Mitchell’s refusal to participate would result in the dismissal of his case. See

Rodgers v. Curators of Univ. of Mo., 135 F.3d 1216, 1219 (8th Cir. 1998) (standard

of review).

Accordingly, we affirm.

A true copy.

Attest:

CLERK, U.S. COURT OF APPEALS, EIGHTH CIRCUIT.
# L_2023106EN.01006901.xml

| 20.4.2023 | EN | Official Journal of the European Union | L 106/69 |
| --- | --- | --- | --- |

20.4.2023

EN

Official Journal of the European Union

L 106/69

---

DECISION OF THE EEA JOINT COMMITTEE No 266/2022

of 23 September 2022

amending Annex XX (Environment) to the EEA Agreement [2023/795]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

| (1) | Commission Implementing Decision (EU) 2022/252 of 21 February 2022 amending Implementing Decision (EU) 2020/1167 in order to specify the testing requirements to be applied to a 48 Volt efficient motor generator integrated in the transmission housing and combined with a 48 Volt/12 Volt DC/DC converter (1) is to be incorporated into the EEA Agreement. |
| --- | --- |

(1)

Commission Implementing Decision (EU) 2022/252 of 21 February 2022 amending Implementing Decision (EU) 2020/1167 in order to specify the testing requirements to be applied to a 48 Volt efficient motor generator integrated in the transmission housing and combined with a 48 Volt/12 Volt DC/DC converter (1) is to be incorporated into the EEA Agreement.

| (2) | Annex XX to the EEA Agreement should therefore be amended accordingly, |
| --- | --- |

(2)

Annex XX to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following indent is added in point 21azd (Commission Implementing Decision (EU) 2020/1167) of Annex XX to the EEA Agreement:

| ‘— | 32022 D 0252: Commission Implementing Decision (EU) 2022/252 of 21 February 2022 (OJ L 41, 22.2.2022, p. 33).’ |
| --- | --- |

‘—

32022 D 0252: Commission Implementing Decision (EU) 2022/252 of 21 February 2022 (OJ L 41, 22.2.2022, p. 33).’

Article 2

The text of Implementing Decision (EU) 2022/252 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 24 September 2022, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 23 September 2022.

For the EEA Joint Committee

The President

Kristján Andri STEFÁNSSON

---

(1)  
  OJ L 41, 22.2.2022, p. 33.

1

(*)  No constitutional requirements indicated.

*

---
### §4505. Payments for commercial products and commercial services

(a) Terms and Conditions for Payments.—Payments under section 4501 of this title for commercial products or commercial services may be made under terms and conditions that the head of the executive agency determines are appropriate or customary in the commercial marketplace and are in the best interests of the Federal Government.

(b) Security for Payments.—The head of the executive agency shall obtain adequate security for the payments. If the security is in the form of a lien in favor of the Federal Government, the lien is paramount to all other liens and is effective immediately on the first payment, without filing, notice, or other action by the Federal Government.

(c) Limitation on Advance Payments.—Advance payments made under section 4501 of this title for commercial products or commercial services may include payments, in a total amount not more than 15 percent of the contract price, in advance of any performance of work under the contract.

(d) Nonapplication of Certain Conditions.—The conditions of sections 4503 and 4504 of this title need not be applied if they would be inconsistent, as determined by the head of the executive agency, with commercial terms and conditions pursuant to this section.

(Pub. L. 111–350, §3, Jan. 4, 2011, 124 Stat. 3791; Pub. L. 115–232, div. A, title VIII, §836(b)(18)(A), (B)(i), Aug. 13, 2018, 132 Stat. 1864.)

| Revised Section | Source (U.S. Code) | Source (Statutes at Large) |
| --- | --- | --- |
| 4505 | 41:255(f). | June 30, 1949, ch. 288, title III, §305(f), as added Pub. L. 103–355, title II, §2051(e), Oct. 13, 1994, 108 Stat. 3304, as amended Pub. L. 104–106, title XLIII, §4321(a)(4), Feb. 10, 1996, 110 Stat. 671. |

Section

#### **Editorial Notes**

#### Amendments

2018—Pub. L. 115–232, §836(b)(18)(B)(i), substituted "Payments for commercial products and commercial services" for "Payments for commercial items" in section catchline.

Subsecs. (a), (c). Pub. L. 115–232, §836(b)(18)(A), substituted "commercial products or commercial services" for "commercial items".

#### **Statutory Notes and Related Subsidiaries**

#### Effective Date of 2018 Amendment

Amendment by Pub. L. 115–232 effective Jan. 1, 2020, subject to a savings provision, see section 836(h) of Pub. L. 115–232, set out as an Effective Date of 2018 Amendment; Savings Provision note under section 453b of Title 6, Domestic Security.
### **CHAPTER 63—LEAD-BASED PAINT POISONING PREVENTION**

#### SUBCHAPTER I—GRANTS FOR DETECTION AND TREATMENT OF LEAD-BASED PAINT POISONING

Sec.
4801.
Repealed.

#### SUBCHAPTER II—GRANTS FOR ELIMINATION OF LEAD-BASED PAINT POISONING

4811.
Repealed.

#### SUBCHAPTER III—FEDERAL DEMONSTRATION AND RESEARCH PROGRAM: FEDERAL HOUSING ADMINISTRATION REQUIREMENTS

4821.
Development of program; consultation; nature of program; safe level of lead; report to Congress.
4822.
Requirements for housing receiving Federal assistance.

#### SUBCHAPTER IV—PROHIBITION AGAINST FUTURE USE OF LEAD-BASED PAINT

4831.
Use of lead-based paint.

#### SUBCHAPTER V—GENERAL PROVISIONS

4841.
Definitions.
4842.
Consultation by Secretary with other departments and agencies.
4843.
Authorization of appropriations.
4844, 4845. Repealed.
4846.
State laws superseded, and null and void.
### Part B—Electricity Generation and Use
### Part I—C.W. Bill Young Cell Transplantation Program

#### **Editorial Notes**

#### Codification

Pub. L. 109–129, §3(e), Dec. 20, 2005, 119 Stat. 2562, substituted "C.W. Bill Young Cell Transplantation Program" for "National Bone Marrow Donor Registry" in part heading.

Pub. L. 101–616, title I, §101(a)(2), Nov. 16, 1990, 104 Stat. 3279, added part I "National Bone Marrow Donor Registry" and redesignated former part I "Biomedical Ethics" as J.

Pub. L. 99–158, §§3(b), 11, Nov. 20, 1985, 99 Stat. 879, 883, added part I "Biomedical Ethics", and repealed former part I "National Library of Medicine".

Pub. L. 91–212, §10(a)(2), Mar. 13, 1970, 84 Stat. 66, redesignated part H "National Library of Medicine", as I. Former part I "Assistance to Medical Libraries" redesignated J.
EXHIBIT 32.1
                            CERTIFICATION PURSUANT TO
                                 18 U.S.C. 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly  Report of Cancer  Detection  Corporation  (the
"Company")  on Form 10-Q for the period ended  November 30, 2008,  as filed with
the Securities  and Exchange  Commission on the date hereof (the  "Report"),  I,
David  Kittrell,  Chief  Executive  Officer and Chief  Financial  Officer of the
Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and

The  information  contained  in the  Report  fairly  presents,  in all  material
respects, the financial condition and results of operations of the Company.



Date: January 15, 2009


By:       /s/ David Kittrell
         -----------------------------
         David Kittrell
         Chief Executive Officer and
         Chief Financial Officer
EXHIBIT 10.44





March 29, 2011





Dr. Gerald Burnett


1476 Cyprus Drive


Pebble Beach, CA 93953





Avistar Communications Corporation


1875 South Grant Street, 10th Floor


San Mateo, CA 94112





To Whom It May Concern:





If needed, I, Dr. Gerald Burnett, will fund Avistar Communications Corporation (“Avistar”) through March 31, 2012, with the same mechanism and terms that currently secures Avistar’s existing $8.0 million revolving line of credit that terminates on December 22, 2011, up to a total dollar amount of $8.0 million.











/s/ Gerald BurnettDr. Gerald Burnett
§ 734.6 Assistance available from BIS for determining licensing and other requirements. ( a ) If you are not sure whether a commodity, software, technology, or activity “subject to the EAR” is subject to licensing or other requirements under the EAR, you may ask BIS for an advisory opinion or a commodity classification determination. In order to determine whether an item is “subject to the ITAR,” you should review the ITAR's United States Munitions List (see 22 CFR 120.3, 120.6 and 121.1). You may also submit a request to the Department of State, Directorate of Defense Trade Controls, for a formal jurisdictional determination regarding the commodity, software, technology, or activity at issue; or in ITAR terms, the defense article, technical data or defense service at issue (see 22 CFR 120.4).
( b ) As the agency responsible for administering the EAR, BIS is the only agency that has the responsibility for determining whether an item or activity is subject to the EAR and, if so, what licensing or other requirements apply under the EAR. Such a determination only affects EAR requirements, and does not affect the applicability of any other regulatory programs.
( c ) If you need help in determining BIS licensing or other requirements you may ask BIS for help by following the procedures described in § 748.3 of the EAR.
[61 FR 12746, Mar. 25, 1996, as amended at 78 FR 61900, Oct. 4, 2013]
### SUBCHAPTER III—GRANTS FOR STATE AND COMMUNITY PROGRAMS ON AGING
[Federal Register Volume 69, Number 220 (Tuesday, November 16, 2004)]
[Notices]
[Page 67169]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-25434]


-----------------------------------------------------------------------

DEPARTMENT OF THE INTERIOR

National Park Service


National Park System Advisory Board; Meeting

AGENCY: National Park Service, Interior.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

    Notice is hereby given in accordance with the Federal Advisory 
Committee Act, 5 U.S.C. Appendix, that the National Park System 
Advisory Board will meetNovember 29-30, 2004, in Coral Gables, Florida. 
On November 29, the Board will tour Everglades National Park and will 
be briefed regarding environmental, education and partnership programs 
of Everglades National Park and Big Cypress National Preserve. The 
Board will convene its business meeting on November 30 at 9 a.m., 
e.s.t., in the Prado Room of The Biltmore Hotel, 1200 Anastasia Avenue, 
Coral Gables, Florida 33134, telephone 305-445-1926. The meeting will 
be adjourned at 4:30 p.m. The Board will be addressed by National Park 
Service Director Fran Mainella and will receive the reports of its 
Education Committee, Partnerships Committee, National Landmarks 
Committee, Director's Council, and National Parks Science Committee. 
The Board also will receive reports on national park philanthropic 
issues and the HealthierFeds Physical Activity Challenge.
    Other officials of the National Park Service and the Department of 
the Interior may address the Board, and other miscellaneous topics and 
reports may be covered. The order of the agenda may be changed, if 
necessary, to accommodate travel schedules or for other reasons.
    The Board meeting will be open to the public. Space and facilities 
to accommodate the public are limited and attendees will be 
accommodated on a first-come basis. Anyone may file with the Board a 
written statement concerning matters to be discussed. The Board also 
may permit attendees to address the Board, but may restrict the length 
of the presentations, as necessary to allow the Board to complete its 
agenda within the allotted time.
    Anyone who wishes further information concerning the meeting, or 
who wishes to submit a written statement, may contact Mr. Loran Fraser, 
Office of Policy, National Park Service; 1849 C Street, NW., Room 7250; 
Washington, DC 20240; telephone 202-208-7456.
    Draft minutes of the meeting will be available for public 
inspection about 12 weeks after the meeting, in room 7252, Main 
Interior Building, 1849 C Street, NW., Washington, DC.

    Dated: November 8, 2004.
Bernard Fagan,
Deputy Chief, Office of Policy.
[FR Doc. 04-25434 Filed 11-15-04; 8:45 am]
BILLING CODE 4312-52-P
§ 743.8 Reporting on quantum deemed exports and deemed reexports. ( a ) *Requirement.* A report must be submitted to BIS in accordance with this section for the deemed export or deemed reexport under General License in General Order no. 6 in paragraph (f)(3) of supplement no. 1 to part 736 of the EAR to foreign person employees whose most recent country of citizenship or permanent residency is a destination specified in Country Group D:1 or D:5 of quantum “software” or “technology” specified in the following ECCNs: 3D901 (for 3A901.b, 3B904), 3E901 (for 3A901, 3A904, 3B904, 3C907, 3C908, 3C909), 4D906, or 4E906.
( b ) *Party responsible for reporting.* The entity who released the specified “software” or “technology” must ensure the reports required by this section are properly submitted to BIS.
( c ) *Information to be included in the reports.* The report must include the following: ( 1 ) The name, address and point of contact of the entity that made the release;
( 2 ) Description of the “software” or “technology;”
( 3 ) Foreign person information, including all the information that would be provided in a deemed export license application, see guidelines for deemed export license applications under the learn and support tab of the BIS website at *www.bis.gov ;*
( 4 ) End item of the “technology” or “software” including a description and ECCN of the end item (if known); and
( 5 ) The exporting company's name and address must appear at the top of each page.
( d ) *Annual reporting requirement.* ( 1 ) You must submit the first report on November 5, 2024 subject to the provisions of this section. The report shall cover any releases during the time between September 6, 2024 and October 28, 2024. Thereafter, reports are due according to the provisions of paragraph (d)(2) of this section.
( 2 ) Reports for the reporting period ending December 31 must be received by BIS no later than February 1.
( e ) *Termination reporting.* When a foreign person, who has had access to “software” or “technology” identified in paragraph (a) of this section, leaves your employment or academic institution, you must report the name, host company or university, and if known, if they are leaving the United States to go be employed in a destination specified in Country Group D;1 or D:5 or if they are leaving to change employer or university within the United States. This report is due within 30 days of the foreign person's last day with the host company or university.
( f ) *Where to submit Quantum General License reports* —Report may be emailed to *EAR.Reports@bis.doc.gov* and must include “Quantum General License Report” in the subject line.
( g ) *Contacts.* General information concerning the “Quantum General License Report” is available from the Office of National Security Controls, Tel. (202) 482-0092, or Email: *EAR.Reports@bis.doc.gov .*
[89 FR 72939, Sept. 6, 2024]
##### 



EXHIBIT 3.2


CERTIFICATE OF AMENDMENT


OF


RESTATED CERTIFICATE OF INCORPORATION


OF


STRATOS INTERNATIONAL, INC.








| |                                                                                                                                                                                                                                                                                                                                    | 
| | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 
| | A. The total number of shares of capital stock which the
    Corporation shall have authority to issue is 21,000,000,
    consisting of 20,000,000 shares of common stock par value $0.01
    per share (the Common Stock), and 1,000,000 shares
    of preferred stock par value $0.01 per share (the
    Preferred Stock). | 







| |                            
| | ---------------------------
| | STRATOS INTERNATIONAL, INC.



| |     |                         
| | --- | ------------------------
| | By: | /s/  Barry Hollingsworth

| |                                            
| | -------------------------------------------
| |                                            
| | Barry Hollingsworth                        
| | Vice President, Finance and Chief Financial
| | Officer